Epitomee Medical Ltd Cash Flow-to-Debt Ratio
Epitomee Medical Ltd cash flow-to-debt ratio. Epitomee Medical Ltd (EPIT) has a Cash Flow-to-Debt Ratio of -2.02x as of June 2025, meaning its operating cash flow of ILA-12.78 Million could theoretically repay -2% of its total liabilities (ILA6.32 Million) in one year. Check Epitomee Medical Ltd (EPIT) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Epitomee Medical Ltd (2019–2024)
Cash flow-to-debt ratio of Epitomee Medical Ltd from 2019 to 2024. Historical debt coverage capacity for Epitomee Medical Ltd across 6 annual periods. Check EPIT operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Epitomee Medical Ltd Cash Flow-to-Debt Ratio by Year (2019–2024)
Epitomee Medical Ltd cash flow-to-debt ratio by year from 2019 to 2024. Year-by-year debt coverage analysis for Epitomee Medical Ltd. For the full cash flow conversion analysis, see Epitomee Medical Ltd cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (ILA) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.32x | ILA-8.29 Million | ILA6.26 Million | ▲ +8.6% |
| 2023 | -1.45x | ILA-7.92 Million | ILA5.46 Million | ▼ -142.4% |
| 2022 | -0.60x | ILA-9.42 Million | ILA15.76 Million | ▼ -32.1% |
| 2021 | -0.45x | ILA-5.76 Million | ILA12.73 Million | ▼ -216.3% |
| 2020 | 0.39x | ILA6.75 Million | ILA17.34 Million | ▲ +111.1% |
| 2019 | -3.51x | ILA-2.79 Million | ILA794.00K | — |